[Effect of alloxan diabetes on the enzyme activity of the mucous membrane of the small intestine].
Experiments on male rats showed that following subcutaneous injection of alloxan in a dose of 15 mg per 100 g of body weight amylolytic, invertase, glycyl-l-tyrosine dipeptidehydrolase activity of the mucosa of the small intestine altered differently. As a result, there occurred a deviation of the enzymatic spectrum from the normal characterized by a sharp increase (with the development of diabetes) of the activity of the carbohydrate hydrolysing enzymes (amylase and invertase) with a simultaneous reduction of the activity of the enzymes participating in protein (dipeptidase) and fat (monglyceridlipase) hydrolysis.
D000496:Alloxan / Q000008:administration & dosage; D000681:Amylases / Q000378:metabolism; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology*; D004150:Dipeptidases / Q000378:metabolism; D007413:Intestinal Mucosa / Q000201:enzymology*; D008297:Male; D008994:Monoacylglycerol Lipases / Q000378:metabolism; D051381:Rats; D013393:Sucrase / Q000378:metabolism; D013997:Time Factors
D000496:Alloxan; D008994:Monoacylglycerol Lipases; D000681:Amylases; D013393:Sucrase; D004150:Dipeptidases
Vliianie alloksanovogo diabeta na fermentativnuiu aktivnost' slizistoĭ obolochki tonkoĭ kishki.